Cargando…

The assessment of gestational age: a comparison of different methods from a malaria pregnancy cohort in sub-Saharan Africa

BACKGROUND: Determining gestational age in resource-poor settings is challenging because of limited availability of ultrasound technology and late first presentation to antenatal clinic. Last menstrual period (LMP), symphysio-pubis fundal height (SFH) and Ballard Score (BS) at delivery are therefore...

Descripción completa

Detalles Bibliográficos
Autores principales:	Unger, Holger, Thriemer, Kamala, Ley, Benedikt, Tinto, Halidou, Traoré, Maminata, Valea, Innocent, Tagbor, Harry, Antwi, Gifty, Gbekor, Prosper, Nambozi, Michael, Kabuya, Jean-Bertin Bukasa, Mulenga, Modest, Mwapasa, Victor, Chapotera, Gertrude, Madanitsa, Mwayiwawo, Rulisa, Stephen, de Crop, Maaike, Claeys, Yves, Ravinetto, Raffaella, D’Alessandro, Umberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323786/ https://www.ncbi.nlm.nih.gov/pubmed/30621604 http://dx.doi.org/10.1186/s12884-018-2128-z

Ejemplares similares

Artemisinin-based combination therapy during pregnancy: outcome of pregnancy and infant mortality: a cohort study
por: Nambozi, Michael, et al.
Publicado: (2019)

Safe and efficacious artemisinin-based combination treatments for African pregnant women with malaria: a multicentre randomized control trial
por: Nambozi, Michael, et al.
Publicado: (2015)

Fetal biometry assessment with Intergrowth 21st’s and Salomon’s equations in rural Burkina Faso
por: Bihoun, Biébo, et al.
Publicado: (2020)

Age-modified factors associated with placental malaria in rural Burkina Faso
por: Bihoun, Biébo, et al.
Publicado: (2022)

Artemisinin-based combination therapy in pregnant women in Zambia: efficacy, safety and risk of recurrent malaria
por: Nambozi, Michael, et al.
Publicado: (2017)

The return of chloroquine-susceptible Plasmodium falciparum malaria in Zambia
por: Mwanza, Sydney, et al.
Publicado: (2016)

Dihydroartemisinin-Piperaquine and Artemether-Lumefantrine for Treating Uncomplicated Malaria in African Children: A Randomised, Non-Inferiority Trial
por: Bassat, Quique, et al.
Publicado: (2009)

In Vivo Antiplasmodial Activity of Two Sahelian Plant Extracts on Plasmodium berghei ANKA Infected NMRI Mice
por: Bonkian, Léa Nadège, et al.
Publicado: (2018)

A microplanning model to improve door-to-door health service delivery: the case of Seasonal Malaria Chemoprevention in Sub-Saharan African villages
por: Ouédraogo, André Lin, et al.
Publicado: (2020)

Safety of antimalarial drugs exposure during early pregnancy
por: Tagbor, Harry, et al.
Publicado: (2014)

Prospective observational study to evaluate the clinical and biological safety profile of pyronaridine–artesunate in a rural health district in Burkina Faso
por: Rouamba, Toussaint, et al.
Publicado: (2022)

Population pharmacokinetics of artesunate and dihydroartemisinin in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Burkina Faso: an open label trial
por: Birgersson, Sofia, et al.
Publicado: (2020)

Safety and efficacy of intermittent presumptive treatment with sulfadoxine-pyrimethamine using rapid diagnostic test screening and treatment with dihydroartemisinin-piperaquine at the first antenatal care visit (IPTp-SP+): study protocol for a randomized controlled trial
por: Kabuya, Jean-Bertin Bukasa, et al.
Publicado: (2021)

Safety of Daily Co-Trimoxazole in Pregnancy in an Area of Changing Malaria Epidemiology: A Phase 3b Randomized Controlled Clinical Trial
por: Manyando, Christine, et al.
Publicado: (2014)

High adherence level to artemisinin-based combination therapies in rural settlement 11 years after their introduction in the health system, Nanoro, Burkina Faso
por: Rouamba, Toussaint, et al.
Publicado: (2019)

Defining the malaria burden in Nchelenge District, northern Zambia using the World Health Organization malaria indicators survey
por: Nambozi, Michael, et al.
Publicado: (2014)

In vivo/ex vivo efficacy of artemether–lumefantrine and artesunate–amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso
por: Lingani, Moussa, et al.
Publicado: (2020)

Ex vivo anti-malarial drug susceptibility of Plasmodium falciparum isolates from pregnant women in an area of highly seasonal transmission in Burkina Faso
por: Tahita, Marc C, et al.
Publicado: (2015)

Efficacy and safety of artemether–lumefantrine as treatment for Plasmodium falciparum uncomplicated malaria in adult patients on efavirenz-based antiretroviral therapy in Zambia: an open label non-randomized interventional trial
por: Banda, Clifford G., et al.
Publicado: (2019)

Malaria incidence and prevalence during the first year of life in Nanoro, Burkina Faso: a birth-cohort study
por: Natama, Hamtandi Magloire, et al.
Publicado: (2018)

Genetic variation in the immune system and malaria susceptibility in infants: a nested case–control study in Nanoro, Burkina Faso
por: Natama, Hamatandi Magloire, et al.
Publicado: (2021)

Safety Profile of Drug Use During Pregnancy at Peripheral Health Centres in Burkina Faso: A Prospective Observational Cohort Study
por: Rouamba, Toussaint, et al.
Publicado: (2018)

Knowledge, attitude and perception on antimicrobial use and antimicrobial resistance among final year medical students in the College of Medicine, Malawi
por: Kamoto, Alfred, et al.
Publicado: (2020)

The impact of clinical research activities on communities in rural Africa: the development of the Clinical Research Unit of Nanoro (CRUN) in Burkina Faso
por: Tinto, Halidou, et al.
Publicado: (2014)

Joint modelling of multivariate longitudinal clinical laboratory safety outcomes, concomitant medication and clinical adverse events: application to artemisinin-based treatment during pregnancy clinical trial
por: Patson, Noel, et al.
Publicado: (2021)

Intermittent screening and treatment with artemisinin-combination therapy versus intermittent preventive treatment with sulphadoxine-pyrimethamine for malaria in pregnancy: a systematic review and individual participant data meta-analysis of randomised clinical trials
por: Gutman, Julie R, et al.
Publicado: (2021)

Intermittent preventive treatment of malaria with sulphadoxine-pyrimethamine during pregnancy in Burkina Faso: effect of adding a third dose to the standard two-dose regimen on low birth weight, anaemia and pregnancy outcomes
por: Valea, Innocent, et al.
Publicado: (2010)

Prevalence and risk factors of malaria among first antenatal care attendees in rural Burkina Faso
por: Lingani, Moussa, et al.
Publicado: (2022)

Population-based incidence, seasonality and serotype distribution of invasive salmonellosis among children in Nanoro, rural Burkina Faso
por: Guiraud, Issa, et al.
Publicado: (2017)

Modulation of innate immune responses at birth by prenatal malaria exposure and association with malaria risk during the first year of life
por: Natama, Hamtandi Magloire, et al.
Publicado: (2018)

Association of malaria and curable sexually transmitted infections with pregnancy outcomes in rural Burkina Faso
por: Zango, Serge Henri, et al.
Publicado: (2021)

Magnitude of low birthweight in malaria endemic settings of Nanoro, rural Burkina Faso: a secondary data analysis
por: Lingani, Moussa, et al.
Publicado: (2021)

Seasonal malaria chemoprevention in an area of extended seasonal transmission in Ashanti, Ghana: an individually randomised clinical trial
por: Tagbor, Harry, et al.
Publicado: (2015)

Assessment of a combined strategy of seasonal malaria chemoprevention and supplementation with vitamin A, zinc and Plumpy’Doz™ to prevent malaria and malnutrition in children under 5 years old in Burkina Faso: a randomized open-label trial (SMC-NUT)
por: Sondo, Paul, et al.
Publicado: (2021)

Safety and efficacy of dihydroartemisinin-piperaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Zambian children
por: Nambozi, Michael, et al.
Publicado: (2011)

Intermittent screening and treatment with dihydroartemisinin-piperaquine and intermittent preventive therapy with sulfadoxine-pyrimethamine have similar effects on malaria antibody in pregnant Malawian women
por: Teo, Andrew, et al.
Publicado: (2019)

Prevalence and factors associated with carriage of Pfmdr1 polymorphisms among pregnant women receiving intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-SP) and artemether-lumefantrine for malaria treatment in Burkina Faso
por: Natama, Hamtandi Magloire, et al.
Publicado: (2020)

An analysis of timing and frequency of malaria infection during pregnancy in relation to the risk of low birth weight, anaemia and perinatal mortality in Burkina Faso
por: Valea, Innocent, et al.
Publicado: (2012)

Dynamic of plasmodium falciparum chloroquine resistance transporter gene Pfcrt K76T mutation five years after withdrawal of chloroquine in Burkina Faso
por: Sondo, Paul, et al.
Publicado: (2015)

Determinants of Plasmodium falciparum multiplicity of infection and genetic diversity in Burkina Faso
por: Sondo, Paul, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rno5o29hmplo7ifhh2iss42ioe